• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2-芳氧基苯甲醛 N-酰腙和 1,3,4-恶二唑衍生物的细胞毒性活性及对接研究及其对各种癌细胞系的作用。

Cytotoxic Activity and Docking Studies of 2-arenoxybenzaldehyde N-acyl Hydrazone and 1,3,4-Oxadiazole Derivatives against Various Cancer Cell Lines.

机构信息

Center of Drug Discovery and Development, Research Institute for Health Sciences and Technologies SABITA, Istanbul Medipol University, 34810 Istanbul, Turkey.

Department of Molecular Medicine, and Biotechnology, Health Sciences Institute, Istanbul Medipol University, 34810 Istanbul, Turkey.

出版信息

Molecules. 2022 Oct 27;27(21):7309. doi: 10.3390/molecules27217309.

DOI:10.3390/molecules27217309
PMID:36364134
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9657749/
Abstract

To understand whether previously synthesized novel hydrazone and oxadiazole derivatives have promising anticancer effects, docking studies and in vitro toxicity assays were performed on A-549, MDA-MB-231, and PC-3 cell lines. The antiproliferative properties of the compounds were investigated using molecular docking experiments. Each compound's best-docked poses, binding affinity, and receptor-ligand interaction were evaluated. Compounds' molecular weights, logPs, TPSAs, abilities to pass the blood-brain barrier, GI absorption qualities, and CYPP450 inhibition have been given. When the activities of these molecules were examined in vitro, for the A-549 cell line, hydrazone had the minimum IC value of 13.39 μM. For the MDA-MB-231 cell line, oxadiazole demonstrated the lowest IC value, with 22.73 μM. For PC-3, hydrazone showed the lowest C50 value of 9.38 μM. The three most promising compounds were determined as compounds , , and based on their minimum IC values, and an additional scratch assay was performed for A-549 and MDA-MB-231 cells, which have high migration capacity, for the three most potent molecules; it was determined that these molecules did not show a significant antimetastatic effect.

摘要

为了研究先前合成的新型腙和噁二唑衍生物是否具有有前景的抗癌作用,我们对 A-549、MDA-MB-231 和 PC-3 细胞系进行了对接研究和体外毒性检测。采用分子对接实验研究了这些化合物的抗增殖特性。评估了每个化合物的最佳对接构象、结合亲和力和受体-配体相互作用。还给出了化合物的分子量、logP 值、TPSA 值、通过血脑屏障的能力、GI 吸收质量和 CYP450 抑制能力。当在体外研究这些分子的活性时,对于 A-549 细胞系,腙 具有最低的 IC 值 13.39 μM。对于 MDA-MB-231 细胞系,噁二唑 显示出最低的 IC 值,为 22.73 μM。对于 PC-3,腙 显示出最低的 C50 值 9.38 μM。基于最低的 IC 值,确定了三种最有前途的化合物, 和 ,并对具有高迁移能力的 A-549 和 MDA-MB-231 细胞进行了划痕实验,结果表明这三种最有效的分子没有表现出明显的抗转移作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c8/9657749/6286c5a0b672/molecules-27-07309-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c8/9657749/aacc39fe015c/molecules-27-07309-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c8/9657749/e5e8ce513c15/molecules-27-07309-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c8/9657749/f3439d331810/molecules-27-07309-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c8/9657749/6286c5a0b672/molecules-27-07309-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c8/9657749/aacc39fe015c/molecules-27-07309-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c8/9657749/e5e8ce513c15/molecules-27-07309-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c8/9657749/f3439d331810/molecules-27-07309-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c8/9657749/6286c5a0b672/molecules-27-07309-g011.jpg

相似文献

1
Cytotoxic Activity and Docking Studies of 2-arenoxybenzaldehyde N-acyl Hydrazone and 1,3,4-Oxadiazole Derivatives against Various Cancer Cell Lines.2-芳氧基苯甲醛 N-酰腙和 1,3,4-恶二唑衍生物的细胞毒性活性及对接研究及其对各种癌细胞系的作用。
Molecules. 2022 Oct 27;27(21):7309. doi: 10.3390/molecules27217309.
2
Molecular Hybrid Design, Synthesis, In Vitro Cytotoxicity, In Silico ADME and Molecular Docking Studies of New Benzoate Ester-Linked Arylsulfonyl Hydrazones.新型苯甲酸酯键合芳基磺酰基腙的分子杂化设计、合成、体外细胞毒性、计算机辅助药物代谢和分子对接研究。
Molecules. 2024 Jul 25;29(15):3478. doi: 10.3390/molecules29153478.
3
Novel Hydrazone Derivatives of 3-Bromopyruvate: Synthesis, Evaluation of the Cytotoxic Effects, Molecular Docking and ADME Studies.新型 3-溴丙酮酸腙衍生物的合成、细胞毒性评价、分子对接和 ADME 研究。
Chem Biodivers. 2022 Jun;19(6):e202100754. doi: 10.1002/cbdv.202100754. Epub 2022 Apr 28.
4
Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities, ADME and Molecular Docking Studies.酰肼腙类小分子原肌球蛋白受体激酶A(TRKA)抑制剂:合成、抗癌活性、药物代谢动力学及分子对接研究
Med Chem. 2022;19(1):47-63. doi: 10.2174/1573406418666220427105041.
5
Design, synthesis, modelling studies and biological evaluation of 1,3,4-oxadiazole derivatives as potent anticancer agents targeting thymidine phosphorylase enzyme.设计、合成、建模研究和生物评价 1,3,4-噁二唑衍生物作为靶向胸苷磷酸化酶的有效抗癌剂。
Bioorg Chem. 2021 Jun;111:104873. doi: 10.1016/j.bioorg.2021.104873. Epub 2021 Mar 29.
6
Synthesis, cytotoxicity, and molecular docking of substituted 3-(2-methylbenzofuran-3-yl)-5-(phenoxymethyl)-1,2,4-oxadiazoles.取代的 3-(2-甲基苯并呋喃-3-基)-5-(苯氧甲基)-1,2,4-恶二唑的合成、细胞毒性及分子对接。
Arch Pharm (Weinheim). 2020 Jun;353(6):e2000006. doi: 10.1002/ardp.202000006. Epub 2020 Apr 20.
7
Design, synthesis and docking studies of novel 4-aminophenol-1,2,4-oxadiazole hybrids as apoptosis inducers against triple negative breast cancer cells targeting MAP kinase.新型 4-氨基酚-1,2,4-恶二唑杂合体的设计、合成及对接研究,作为针对 MAP 激酶的三阴性乳腺癌细胞凋亡诱导剂。
J Biomol Struct Dyn. 2024 Jul;42(11):5841-5857. doi: 10.1080/07391102.2023.2239912. Epub 2023 Aug 2.
8
Synthesis and Evaluation of Novel Metacetamol Derivatives with Hydrazone Moiety as Anticancer and Antimicrobial Agents.新型米他唑仑腙类衍生物的合成与评价及其作为抗癌和抗菌剂的研究。
Chem Biodivers. 2023 Aug;20(8):e202300766. doi: 10.1002/cbdv.202300766. Epub 2023 Jul 17.
9
A new series of thiazole-hydrazone hybrids for Akt-targeted therapy of non-small cell lung cancer.用于非小细胞肺癌Akt靶向治疗的新型噻唑腙杂化物系列
Drug Dev Res. 2023 Apr;84(2):185-199. doi: 10.1002/ddr.22022. Epub 2022 Dec 5.
10
Novel 1,3,4-thiadiazole/oxadiazole-linked honokiol derivatives suppress cancer via inducing PI3K/Akt/mTOR-dependent autophagy.新型 1,3,4-噻二唑/噁二唑连接型厚朴酚衍生物通过诱导 PI3K/Akt/mTOR 依赖性自噬抑制癌症。
Bioorg Chem. 2021 Oct;115:105257. doi: 10.1016/j.bioorg.2021.105257. Epub 2021 Aug 10.

引用本文的文献

1
Biological Evaluation and Computational Modelling Studies on -acyl Hydrazone and 2,5-Disubstituted 1,3,4-Oxadiazole Derivatives as Non-toxic Antimicrobial Agents.酰腙和2,5-二取代-1,3,4-恶二唑衍生物作为无毒抗菌剂的生物学评价与计算建模研究
Curr Pharm Des. 2025;31(32):2611-2624. doi: 10.2174/0113816128361524250131110036.
2
Synthesis of an aggregation-induced emission-based fluorescent probe based on rupestonic acid.基于石蒜酸的聚集诱导发光荧光探针的合成
RSC Adv. 2023 Sep 1;13(36):25369-25378. doi: 10.1039/d3ra03521b. eCollection 2023 Aug 21.
3
Novel -Acyl Hydrazone Compounds as Promising Anticancer Agents: Synthesis and Molecular Docking Studies.

本文引用的文献

1
Discovery of Novel -Aminophosphonates with Hydrazone as Potential Antiviral Agents Combined With Active Fragment and Molecular Docking.以腙为潜在抗病毒剂并结合活性片段和分子对接的新型氨基膦酸酯的发现
Front Chem. 2022 May 20;10:911453. doi: 10.3389/fchem.2022.911453. eCollection 2022.
2
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
3
Antibacterial and Antiviral Activities of 1,3,4-Oxadiazole Thioether 4-Chromen-4-one Derivatives.1,3,4-恶二唑硫醚 4-色烯-4-酮衍生物的抗菌和抗病毒活性。
新型酰腙化合物作为有前景的抗癌剂:合成与分子对接研究
ACS Omega. 2023 May 20;8(22):20073-20084. doi: 10.1021/acsomega.3c02361. eCollection 2023 Jun 6.
J Agric Food Chem. 2021 Sep 22;69(37):11085-11094. doi: 10.1021/acs.jafc.1c03755. Epub 2021 Sep 13.
4
Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives.1,3,4-恶二唑衍生物的抗菌活性。
Int J Mol Sci. 2021 Jun 29;22(13):6979. doi: 10.3390/ijms22136979.
5
Free radical scavenging mechanism of 1,3,4-oxadiazole derivatives: thermodynamics of O-H and N-H bond cleavage.1,3,4-恶二唑衍生物的自由基清除机制:O-H和N-H键断裂的热力学
Heliyon. 2020 Mar 31;6(3):e03683. doi: 10.1016/j.heliyon.2020.e03683. eCollection 2020 Mar.
6
Synthesis and evaluation of 1,3,4-oxadiazole derivatives for development as broad-spectrum antibiotics.合成和评估 1,3,4-噁二唑衍生物,以开发为广谱抗生素。
Bioorg Med Chem. 2019 Nov 1;27(21):115097. doi: 10.1016/j.bmc.2019.115097. Epub 2019 Sep 10.
7
Synthesis of New Hydrazone Derivatives and Evaluation of their Efficacy as Proliferation Inhibitors in Human Cancer Cells.新型腙衍生物的合成及其作为人癌细胞增殖抑制剂的功效评价。
Med Chem. 2019;15(8):903-910. doi: 10.2174/1573406415666190128100524.
8
Anti-Cancer Activity of Derivatives of 1,3,4-Oxadiazole.1,3,4-恶二唑衍生物的抗癌活性。
Molecules. 2018 Dec 18;23(12):3361. doi: 10.3390/molecules23123361.
9
Design, Synthesis and Docking Studies of Flavokawain B Type Chalcones and Their Cytotoxic Effects on MCF-7 and MDA-MB-231 Cell Lines.Flavokawain B 型查尔酮的设计、合成及对接研究及其对 MCF-7 和 MDA-MB-231 细胞系的细胞毒性作用。
Molecules. 2018 Mar 8;23(3):616. doi: 10.3390/molecules23030616.
10
Potent hydrazone derivatives targeting esophageal cancer cells.靶向食管癌的有效腙衍生物。
Eur J Med Chem. 2018 Mar 25;148:359-371. doi: 10.1016/j.ejmech.2018.02.033. Epub 2018 Feb 14.